Status:
COMPLETED
Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Intubation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Emergency intubation of patients in intensive care is a high-risk endeavour. For many decades, succinylcholine has been the neuromuscular blocking agent of choice. However, succinylcholine may have li...
Detailed Description
Objective: to compare succinylcholine and rocuronium with regard to 1) quality of intubating conditions, 2) length of the intubating sequence, 3) failed intubating attempts, 4) hemodynamic sequelae of...
Eligibility Criteria
Inclusion
- indication for emergency intubation in intensive care
- availability of qualified study physician
Exclusion
- contraindication against succinylcholine or rocuronium
- indication for awake fibreoptic intubation
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT00355368
Start Date
August 1 2006
End Date
July 1 2010
Last Update
December 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medical Intensive Care; University of Basel
Basel, Canton of Basel-City, Switzerland, 4031